Skip to main content
Clinical Trials/CTRI/2022/06/043589
CTRI/2022/06/043589
Completed
Phase 3

A randomized comparative interventional study to assess the efficacy of Belladonna and Bryonia alba on inflammatory modulations produced in the cases of Rheumatoid arthritis through variations in c reactive protein readings

HOMOEOPATHY UNIVERSITY0 sites87 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
HOMOEOPATHY UNIVERSITY
Enrollment
87
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
July 7, 2023
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
HOMOEOPATHY UNIVERSITY

Eligibility Criteria

Inclusion Criteria

  • 1Clinically diagnosed patients of rheumatoid arthritis Previously Diagnosed cases of Rheumatoid arthritis reoccurring, with other medicine with no avail.
  • 2Patient’s having CRP variations
  • 3Patients of age group below 65 years and both the sexes will be considered.
  • 4Patient giving consent and maintaining follow up

Exclusion Criteria

  • 1Patients having extra articular manifestations
  • 2Patient are not giving consent and maintaining follow up

Outcomes

Primary Outcomes

Not specified

Similar Trials